These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
384 related items for PubMed ID: 31170954
1. Changes in salivary oxidative status, salivary cortisol, and clinical symptoms in female patients with temporomandibular disorders during occlusal splint therapy: a 3-month follow up. Vrbanović E, Lapić I, Rogić D, Alajbeg IZ. BMC Oral Health; 2019 Jun 06; 19(1):100. PubMed ID: 31170954 [Abstract] [Full Text] [Related]
2. Pain and salivary biomarkers of stress in temperomandibular disorders were affected by maxillary splints. Klepzig K, Wendt J, Teusch L, Rickert C, Kordaß B, Lotze M. J Oral Rehabil; 2024 Jun 06; 51(6):1025-1033. PubMed ID: 38475974 [Abstract] [Full Text] [Related]
3. Salivary Oxidant/Antioxidant Status in Chronic Temporomandibular Disorders Is Dependent on Source and Intensity of Pain - A Pilot Study. Vrbanović E, Alajbeg IZ, Vuletić L, Lapić I, Rogić D, Andabak Rogulj A, Illeš D, Knezović Zlatarić D, Badel T, Alajbeg I. Front Physiol; 2018 Jun 06; 9():1405. PubMed ID: 30386251 [Abstract] [Full Text] [Related]
4. Effect of occlusal splint on oxidative stress markers and psychological aspects of chronic temporomandibular pain: a randomized controlled trial. Alajbeg IZ, Vrbanović E, Lapić I, Alajbeg I, Vuletić L. Sci Rep; 2020 Jul 03; 10(1):10981. PubMed ID: 32620810 [Abstract] [Full Text] [Related]
5. Association of pain intensity, pain-related disability, and depression with hypothalamus-pituitary-adrenal axis function in female patients with chronic temporomandibular disorders. Jo KB, Lee YJ, Lee IG, Lee SC, Park JY, Ahn RS. Psychoneuroendocrinology; 2016 Jul 03; 69():106-15. PubMed ID: 27082645 [Abstract] [Full Text] [Related]
6. Changes in pain intensity and oral health-related quality of life in patients with temporomandibular disorders during stabilization splint therapy--a pilot study. Alajbeg IZ, Gikić M, Valentić-Peruzović M. Acta Clin Croat; 2014 Mar 03; 53(1):7-16. PubMed ID: 24974661 [Abstract] [Full Text] [Related]
7. Salivary cortisol and IgA levels in patients with myofascial pain treated with occlusal appliances in the short term. Doepel M, Söderling E, Ekberg EL, Nilner M, Le Bell Y. J Oral Rehabil; 2009 Mar 03; 36(3):210-6. PubMed ID: 19054288 [Abstract] [Full Text] [Related]
8. Chronic HPA axis response to stress in temporomandibular disorder. Lambert CA, Sanders A, Wilder RS, Slade GD, Van Uum S, Russell E, Koren G, Maixner W. J Dent Hyg; 2013 Apr 03; 87(2):73-81. PubMed ID: 23986140 [Abstract] [Full Text] [Related]
9. Chronic HPA axis response to stress in temporomandibular disorder. Lambert CA, Sanders A, Wilder RS, Slade GD, Van Uum S, Russell E, Koren G, Maixner W. J Dent Hyg; 2014 Apr 03; 88 Suppl 1(Suppl 1):5-12. PubMed ID: 25071145 [Abstract] [Full Text] [Related]
10. Effect of interocclusal appliance on bite force, sleep quality, salivary cortisol levels and signs and symptoms of temporomandibular dysfunction in adults with sleep bruxism. Rosar JV, Barbosa TS, Dias IOV, Kobayashi FY, Costa YM, Gavião MBD, Bonjardim LR, Castelo PM. Arch Oral Biol; 2017 Oct 03; 82():62-70. PubMed ID: 28601734 [Abstract] [Full Text] [Related]
11. Recording the maxillomandibular relationship with the Aqualizer system prior to occlusal splint therapy for treating temporomandibular disorders: a randomized controlled trial. Huth KC, Bex A, Kollmuss M, Wuersching SN. Sci Rep; 2023 Dec 18; 13(1):22535. PubMed ID: 38110552 [Abstract] [Full Text] [Related]
12. Effectiveness of exercise therapy versus occlusal splint therapy for the treatment of painful temporomandibular disorders: a systematic review and meta-analysis. Zhang L, Xu L, Wu D, Yu C, Fan S, Cai B. Ann Palliat Med; 2021 Jun 18; 10(6):6122-6132. PubMed ID: 33977737 [Abstract] [Full Text] [Related]
13. 3D printed versus milled stabilization splints for the management of bruxism and temporomandibular disorders: study protocol for a randomized prospective single-blinded crossover trial. Rabel K, Lüchtenborg J, Linke M, Burkhardt F, Roesner AJ, Nold J, Vach K, Witkowski S, Hillebrecht AL, Spies BC. Trials; 2024 Sep 05; 25(1):589. PubMed ID: 39238023 [Abstract] [Full Text] [Related]
14. Towards an optimal therapy strategy for myogenous TMD, physiotherapy compared with occlusal splint therapy in an RCT with therapy-and-patient-specific treatment durations. van Grootel RJ, Buchner R, Wismeijer D, van der Glas HW. BMC Musculoskelet Disord; 2017 Feb 10; 18(1):76. PubMed ID: 28183288 [Abstract] [Full Text] [Related]
15. Reduced heart rate variability and increased saliva cortisol in patients with TMD. Chinthakanan S, Laosuwan K, Boonyawong P, Kumfu S, Chattipakorn N, Chattipakorn SC. Arch Oral Biol; 2018 Jun 10; 90():125-129. PubMed ID: 29604544 [Abstract] [Full Text] [Related]
16. The evaluation of oxidative stress and inflammation markers in serum and saliva of the patients with temporomandibular disorders. Kazan D, Baş Akkor B, Aksoy A, Atmaca E. Turk J Med Sci; 2023 Jun 10; 53(6):1690-1696. PubMed ID: 38813510 [Abstract] [Full Text] [Related]
17. Internet-Based Multimodal Pain Program With Telephone Support for Adults With Chronic Temporomandibular Disorder Pain: Randomized Controlled Pilot Trial. Lam J, Svensson P, Alstergren P. J Med Internet Res; 2020 Oct 13; 22(10):e22326. PubMed ID: 33048053 [Abstract] [Full Text] [Related]
18. The cortisol response to psychological stress in temporomandibular dysfunction. Jones DA, Rollman GB, Brooke RI. Pain; 1997 Aug 13; 72(1-2):171-82. PubMed ID: 9272801 [Abstract] [Full Text] [Related]
19. Effects of massage therapy and occlusal splint therapy on electromyographic activity and the intensity of signs and symptoms in individuals with temporomandibular disorder and sleep bruxism: a randomized clinical trial. Gomes CA, El Hage Y, Amaral AP, Politti F, Biasotto-Gonzalez DA. Chiropr Man Therap; 2014 Aug 13; 22(1):43. PubMed ID: 25512839 [Abstract] [Full Text] [Related]
20. Effect of occlusal splint on interleukin 6, malondialdehyde and 8-hydroxydeoxyguanosine levels in the synovial fluid of patients with temporomandibular disorders. Baş B, Aksoy A, Atmaca E, Öz AA, Kaya Ö, Kazan D, Yılmaz E, Kütük N. Int J Oral Maxillofac Surg; 2019 Dec 13; 48(12):1558-1563. PubMed ID: 31109746 [Abstract] [Full Text] [Related] Page: [Next] [New Search]